Merrimack 2Q loss narrows on drug payments
14:36 EDT 10 Aug 2012 | Advantage Business Media
Biotech drugmaker Merrimack Pharmaceuticals Inc. said Friday that its second quarter loss narrowed as revenues doubled during its first period as a publicly traded company.The company reported a net loss of $20.1 million, or 22 cents per share, comp..
Original Article: Merrimack 2Q loss narrows on drug payments
More From BioPortfolio on "Merrimack 2Q loss narrows on drug payments"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
